Company / Cash & Equivalents
Heartflow, Inc. Cash & Equivalents History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$44.8M
FY2025
5-year range
$44.8M / $44.8M
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#131 of 148
Health Care
What the data says
Heartflow, Inc.'s cash & equivalents of $45M is lower than 89% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
$45M in FY2025.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 148This company $44.8M Sector average $1.2B
▼
-96.2% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $44.8M | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026